DK110208C - Fremgangsmåde til fremstilling af influenza-vacciner. - Google Patents

Fremgangsmåde til fremstilling af influenza-vacciner.

Info

Publication number
DK110208C
DK110208C DK201165AA DK201165A DK110208C DK 110208 C DK110208 C DK 110208C DK 201165A A DK201165A A DK 201165AA DK 201165 A DK201165 A DK 201165A DK 110208 C DK110208 C DK 110208C
Authority
DK
Denmark
Prior art keywords
preparation
influenza vaccines
influenza
vaccines
Prior art date
Application number
DK201165AA
Other languages
Danish (da)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK110208C publication Critical patent/DK110208C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK201165AA 1964-04-22 1965-04-21 Fremgangsmåde til fremstilling af influenza-vacciner. DK110208C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76450A DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen

Publications (1)

Publication Number Publication Date
DK110208C true DK110208C (da) 1970-12-21

Family

ID=6979080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201165AA DK110208C (da) 1964-04-22 1965-04-21 Fremgangsmåde til fremstilling af influenza-vacciner.

Country Status (13)

Country Link
US (1) US3422187A (de)
AT (1) AT259760B (de)
BE (1) BE662899A (de)
BR (1) BR6569124D0 (de)
CH (1) CH479700A (de)
DE (1) DE1246167B (de)
DK (1) DK110208C (de)
FI (1) FI41428C (de)
FR (1) FR1590063A (de)
GB (1) GB1099555A (de)
LU (1) LU48383A1 (de)
NL (1) NL6505122A (de)
SE (1) SE308575B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085203A (en) * 1972-04-26 1978-04-18 Burroughs Wellcome Co. Process for preparing vaccine
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US20060270248A1 (en) * 2005-05-31 2006-11-30 Gould George L Solvent Management Methods for Gel Production
US9476123B2 (en) 2005-05-31 2016-10-25 Aspen Aerogels, Inc. Solvent management methods for gel production

Also Published As

Publication number Publication date
BE662899A (de)
FI41428B (de) 1969-07-31
LU48383A1 (de) 1966-10-13
BR6569124D0 (pt) 1973-09-20
DE1246167B (de) 1967-08-03
FR1590063A (de) 1970-04-13
NL6505122A (de) 1965-10-25
SE308575B (de) 1969-02-17
FI41428C (fi) 1969-11-10
US3422187A (en) 1969-01-14
GB1099555A (en) 1968-01-17
CH479700A (de) 1969-10-15
AT259760B (de) 1968-02-12

Similar Documents

Publication Publication Date Title
DK112949B (da) Fremgangsmåde til fremstilling af O-mycaminosyl-tylonolid eller dihydro-O-mycaminosyl-tylonolid.
DK117353B (da) Fremgangsmåde til fremstilling af substituerede arylacethydroxamsyrer.
DK113220B (da) Fremgangsmåde til fremstilling af alkanolaminderivater.
DK113435B (da) Fremgangsmåde til fremstilling af 5-nitro-imidazol-forbindelser.
DK118018B (da) Fremgangsmåde til fremstilling af diorganoantimonforbindelser.
DK120194B (da) Fremgangsmåde til fremstilling af azirindinderivater.
DK114699B (da) Fremgangsmåde til fremstilling af furylbenzofuranderivater.
DK113859B (da) Fremgangsmåde til fremstilling af hydroksamsyrer.
DK110208C (da) Fremgangsmåde til fremstilling af influenza-vacciner.
DK115108B (da) Fremgangsmåde til fremstilling af 2-amino-benzophenon-β-oximer.
DK113866B (da) Fremgangsmåde til fremstilling af somatiske antigenvacciner.
DK111891B (da) Fremgangsmåde til fremstilling af 5-oxo-17α-methyl-20-hydroxy-(des-A)-19-nor-pregna-9-en.
DK115694B (da) Fremgangsmåde til fremstilling af α-dithioler.
DK112318B (da) Fremgangsmåde til fremstilling af 2-benzensulfonylamidopyrimidiner.
DK122071B (da) Analogifremgangsmåde til fremstilling af methylenbutyrylphenoler.
DK118945B (da) Fremgangsmåde til fremstilling af 3-phenylpyrrol-derivater.
DK109140C (da) Fremgangsmåde til fremstilling af 1-hydroksy-3-aminopyrrolidon-2-derivater.
DK122880B (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyrer.
DK111884B (da) Fremgangsmåde til fremstilling af estere.
DK106860C (da) Fremgangsmåde til fremstilling af N-alkanoylamino-5-nitro-2-furamidiner.
DK107421C (da) Fremgangsmåde til fremstilling af 17α-ethoxy-6-chlor-6-dehydroprogesteron.
DK125710B (da) Fremgangsmåde til fremstilling af 4-methyl-oxazoler.
DK117148B (da) Fremgangsmåde til fremstilling af substituerede benzofurazaner.
DK118814B (da) Fremgangsmåde til fremstilling af tetracyklin.
DK113292B (da) Fremgangsmåde til fremstilling af azabicycloalkaner.